Cargando…
Baseline interleukin-6 is a prognostic factor for patients with metastatic breast cancer treated with eribulin
PURPOSE: Eribulin is a unique anti-cancer drug which can improve overall survival (OS) of patients with metastatic breast cancer (MBC), probably by modulating the tumor immune microenvironment. The aim of this study was to investigate the clinical significance of serum levels of immune-related and i...
Autores principales: | Bun, Ayako, Nagahashi, Masayuki, Kuroiwa, Mamiko, Komatsu, Miki, Miyoshi, Yasuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564839/ https://www.ncbi.nlm.nih.gov/pubmed/37733188 http://dx.doi.org/10.1007/s10549-023-07086-9 |
Ejemplares similares
-
Overexpressions of Vimentin and Integrins in Human Metastatic Spine Tumors
por: Park, Sung Bae, et al.
Publicado: (2015) -
The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma
por: Yue, Qi, et al.
Publicado: (2013) -
Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme
por: Han, Jing, et al.
Publicado: (2017) -
Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM)
por: Amer, Rehab G., et al.
Publicado: (2022) -
Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016)